Jimmy Flarakos

870 total citations
39 papers, 667 citations indexed

About

Jimmy Flarakos is a scholar working on Molecular Biology, Immunology and Spectroscopy. According to data from OpenAlex, Jimmy Flarakos has authored 39 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Immunology and 7 papers in Spectroscopy. Recurrent topics in Jimmy Flarakos's work include Biosimilars and Bioanalytical Methods (14 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pesticide Residue Analysis and Safety (6 papers). Jimmy Flarakos is often cited by papers focused on Biosimilars and Bioanalytical Methods (14 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pesticide Residue Analysis and Safety (6 papers). Jimmy Flarakos collaborates with scholars based in United States, Switzerland and China. Jimmy Flarakos's co-authors include Paul Vouros, Kenneth L. Morand, Wenkui Li, Yunlin Fu, Francis L. S. Tse, James B. Mangold, Scott J. Harrison, Robert H. Brown, Chris Beecher and Mikhail Bogdanov and has published in prestigious journals such as Analytical Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

Jimmy Flarakos

37 papers receiving 643 citations

Peers

Jimmy Flarakos
Robert A. Carr United States
Xiao Zhu China
John G. Swales United Kingdom
Ming‐Qiang Zhang Netherlands
Susan Cole United Kingdom
Mary E. Lame United States
Robert A. Carr United States
Jimmy Flarakos
Citations per year, relative to Jimmy Flarakos Jimmy Flarakos (= 1×) peers Robert A. Carr

Countries citing papers authored by Jimmy Flarakos

Since Specialization
Citations

This map shows the geographic impact of Jimmy Flarakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimmy Flarakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimmy Flarakos more than expected).

Fields of papers citing papers by Jimmy Flarakos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jimmy Flarakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimmy Flarakos. The network helps show where Jimmy Flarakos may publish in the future.

Co-authorship network of co-authors of Jimmy Flarakos

This figure shows the co-authorship network connecting the top 25 collaborators of Jimmy Flarakos. A scholar is included among the top collaborators of Jimmy Flarakos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jimmy Flarakos. Jimmy Flarakos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tolle, James, Emily DiMango, Michael W. Konstan, et al.. (2023). 122 Pharmacodynamic effects of brensocatib in people with cystic fibrosis. Journal of Cystic Fibrosis. 22. S64–S64.
3.
Fu, Yunlin, Wenkui Li, & Jimmy Flarakos. (2019). Recommendations and Best Practices for Calibration Curves in Quantitative LC–MS Bioanalysis. Bioanalysis. 11(15). 1375–1377. 13 indexed citations
4.
Fu, Yunlin, Wenkui Li, & Jimmy Flarakos. (2018). Highly selective and sensitive LC-MS/MS quantification of a therapeutic protein in human serum using immunoaffinity capture enrichment. Journal of Chromatography B. 1100-1101. 83–90. 8 indexed citations
5.
Li, Wenkui, et al.. (2017). LC–MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard. Journal of Chromatography B. 1044-1045. 166–176. 14 indexed citations
7.
8.
Chen, Xiaohong, Panos Hatsis, Upendra A. Argikar, et al.. (2016). Compound Property Optimization in Drug Discovery Using Quantitative Surface Sampling Micro Liquid Chromatography with Tandem Mass Spectrometry. Analytical Chemistry. 88(23). 11813–11820. 10 indexed citations
9.
Li, Wenkui, et al.. (2015). LC–MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study. Journal of Chromatography B. 983-984. 117–124. 6 indexed citations
10.
Fu, Yunlin, Wenkui Li, Jimmy Flarakos, & Francis L. S. Tse. (2015). Quantitative analysis of pasireotide (SOM230), a cyclic peptide, in monkey plasma using liquid chromatography in combination with tandem mass spectrometry. Journal of Chromatography B. 1008. 242–249. 9 indexed citations
11.
Li, Wenkui, et al.. (2015). Evaluation of plasma microsampling for dried plasma spots (DPS) in quantitative LC-MS/MS bioanalysis using ritonavir as a model compound. Journal of Chromatography B. 991. 46–52. 17 indexed citations
12.
Li, Wenkui, et al.. (2014). A semi-automated LC–MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma. Journal of Chromatography B. 960. 182–193. 6 indexed citations
13.
Kertész, Vilmos, et al.. (2014). Liquid Microjunction Surface Sampling of Acetaminophen, Terfenadine and Their Metabolites in Thin Tissue Sections. Bioanalysis. 6(19). 2599–2606. 15 indexed citations
14.
Lin, Tsung‐Hsien, et al.. (2013). Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry. Cancer Chemotherapy and Pharmacology. 72(1). 181–188. 13 indexed citations
15.
Li, Wenkui, et al.. (2013). Practical Approaches to Incurred Sample LC-MS/MS Reanalysis: Confirming Unexpected Results. Analytical Chemistry. 85(4). 2405–2413. 2 indexed citations
16.
McKeage, Mark J., Peter C.C. Fong, Xiuqin Hong, et al.. (2012). Mass balance, excretion and metabolism of [14C] ASA404 in cancer patients in a phase I trial. Cancer Chemotherapy and Pharmacology. 69(5). 1145–1154. 4 indexed citations
17.
Flarakos, Jimmy, Rosa G. Liberman, Steven R. Tannenbaum, & Paul L. Skipper. (2008). Integration of Continuous-Flow Accelerator Mass Spectrometry with Chromatography and Mass-Selective Detection. Analytical Chemistry. 80(13). 5079–5085. 12 indexed citations
18.
Shaffer, Christopher L., Larry M. Tremaine, Rosa G. Liberman, et al.. (2007). Application of Liquid Chromatography-Accelerator Mass Spectrometry (LC-AMS) to Evaluate the Metabolic Profiles of a Drug Candidate in Human Urine and Plasma. Drug Metabolism Letters. 1(3). 226–231. 18 indexed citations
19.
Rozen, Steve, Merit Cudkowicz, Mikhail Bogdanov, et al.. (2005). Metabolomic analysis and signatures in motor neuron disease. Metabolomics. 1(2). 101–108. 122 indexed citations
20.
Flarakos, Jimmy, et al.. (2003). Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography–mass spectrometry. Journal of Chromatography A. 1026(1-2). 175–183. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026